MesenFlow Technologies SARL Alternatives & Competitors
12 companies similar to MesenFlow Technologies SARL
Companies similar to MesenFlow Technologies SARL
Keen Eye Technologies
AI platform elevates pathology for drug development and diagnostics, supporting all stages...
OCEAN BIOMEDICAL
Empowering great medical science.
Providence, United States
CytRx
Driving Oncology Innovation with Advanced Chemotherapeutic Solutions
NeuCyte
Decoding CNS Drug Discovery with SynFire® iP
Mountain View, United Sta...
Rival Readout
Competing with MesenFlow Technologies SARL? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
7 Hills Pharma
First-in-concept platform of oral drugs to overcome immunotherapy resistance
Houston, United States
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
South San Francisco, Unit...
TRIO - Translational Research in Oncology
Advancing cancer research. Life-changing results.
Edmonton, Canada
InvivoSciences® Inc.
Discovery with Human touch
Madison, United States
NeuroTherapia, Inc.
Treating Neuroinflammation... Treating Disease™
United States
Nordic Bioscience
Improving preclinical and clinical trial success rates with world-leading biomarkers & spe...
Herlev, Denmark
SEngine Precision Medicine
Using 3D organoid technology and proprietary algorithms for effective treatment options an...
Seattle, United States
About MesenFlow Technologies SARL
MesenFlow Technologies SARL is a Swiss-based startup founded in 2016, focusing on accelerating drug and cosmetic development through innovative translational medicine techniques. Spearheaded by Dr. Paul Bradfield and Professor Beat Imhof, the company's platform utilizes 'animal-free' methodologies, including chronic di...
Translational Medicine, Drug Development, Cosmetic Development, Toxicity Assessment, Inflammatory Assessment, Tissue Engineering, Organoid Models, Preclinical Phase, Oncology, Clinical Trials, Translational Technologies, Compound Development, Safety Assessment, Cost Reduction
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around MesenFlow Technologies SARL: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at MesenFlow Technologies SARL on 11 Sep 2024. The 12 companies listed here were last checked between 18 Jul 2024 and 11 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
